£
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

Senior Major Gifts Manager

Location

London

Type of role

Permanent

£42000.00 - £52000.00 dependent on experience

Closing date

27 Jan 2021, 9 a.m.

The Senior Major Gifts Manager is responsible for managing a large portfolio of prospect, donor and key influencer relationships.

They are responsible for developing and advancing these relationships towards clear philanthropic support.

The Major Gifts function sits within the Philanthropy and Partnerships division of Fundraising. The division is responsible for all high value and relationship fundraising from individuals, trusts and corporate partners.

The team includes prospect research support and enjoys a strong relationship and support from our research and other mission teams to identify and develop compelling cases for support on projects and programmes in support of our mission to beat blood cancer.

This role will engage extensively with Fundraising and Mission teams, including significant work with our research community around the UK.

Disability Confident Employer

Blood Cancer UK is a Disability Confident Employer, which means that we seek to provide a workspace which supports the needs of people with disabilities and support the government scheme that promotes the benefits of recruiting and retaining people with disabilities.

Disability Condifdent Employer Stonewall logo

Supporter of diversity

Blood Cancer UK is committed to actively promoting equality, diversity and inclusivity. We seek to create a welcoming and supportive community for the full range of people who are affected by blood cancer, and ensure that our output is fully reflective of this. We are also committed to creating a level playing field as an employer with a welcoming and supportive work environment that meets the needs of all staff. Blood Cancer UK recognises the advantages of employing people from a wide range of backgrounds, and that having a workforce which reflects the diversity of people affected by blood cancer enhances our effectiveness.